Logo image of CNVS

CINEVERSE CORP (CNVS) Stock Fundamental Analysis

NASDAQ:CNVS - Nasdaq - US1724063086 - Common Stock - Currency: USD

3.84  -0.08 (-2.04%)

After market: 3.85 +0.01 (+0.26%)

Fundamental Rating

4

Overall CNVS gets a fundamental rating of 4 out of 10. We evaluated CNVS against 72 industry peers in the Entertainment industry. While CNVS seems to be doing ok healthwise, there are quite some concerns on its profitability. CNVS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CNVS had negative earnings in the past year.
CNVS had a positive operating cash flow in the past year.
In the past 5 years CNVS reported 4 times negative net income.
In multiple years CNVS reported negative operating cash flow during the last 5 years.
CNVS Yearly Net Income VS EBIT VS OCF VS FCFCNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

CNVS has a Return On Assets of -15.30%. This is in the lower half of the industry: CNVS underperforms 73.61% of its industry peers.
CNVS has a worse Return On Equity (-32.93%) than 61.11% of its industry peers.
CNVS's Return On Invested Capital of 11.32% is amongst the best of the industry. CNVS outperforms 88.89% of its industry peers.
Industry RankSector Rank
ROA -15.3%
ROE -32.93%
ROIC 11.32%
ROA(3y)-14.52%
ROA(5y)-28.21%
ROE(3y)-28.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVS Yearly ROA, ROE, ROICCNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

The Operating Margin of CNVS (8.04%) is better than 75.00% of its industry peers.
CNVS's Gross Margin of 53.40% is fine compared to the rest of the industry. CNVS outperforms 61.11% of its industry peers.
In the last couple of years the Gross Margin of CNVS has declined.
Industry RankSector Rank
OM 8.04%
PM (TTM) N/A
GM 53.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.81%
GM growth 5Y-2.67%
CNVS Yearly Profit, Operating, Gross MarginsCNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

5

2. Health

2.1 Basic Checks

CNVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CNVS has more shares outstanding
Compared to 5 years ago, CNVS has more shares outstanding
The debt/assets ratio for CNVS is higher compared to a year ago.
CNVS Yearly Shares OutstandingCNVS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CNVS Yearly Total Debt VS Total AssetsCNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -6.63, we must say that CNVS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -6.63, CNVS is not doing good in the industry: 86.11% of the companies in the same industry are doing better.
The Debt to FCF ratio of CNVS is 1.79, which is an excellent value as it means it would take CNVS, only 1.79 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.79, CNVS belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that CNVS is not too dependend on debt financing.
CNVS has a better Debt to Equity ratio (0.10) than 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.79
Altman-Z -6.63
ROIC/WACC1.3
WACC8.74%
CNVS Yearly LT Debt VS Equity VS FCFCNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.15 indicates that CNVS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.15, CNVS perfoms like the industry average, outperforming 56.94% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that CNVS should not have too much problems paying its short term obligations.
CNVS has a Quick ratio of 1.15. This is comparable to the rest of the industry: CNVS outperforms 59.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
CNVS Yearly Current Assets VS Current LiabilitesCNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.98% over the past year.
Looking at the last year, CNVS shows a very strong growth in Revenue. The Revenue has grown by 39.86%.
Measured over the past years, CNVS shows a decrease in Revenue. The Revenue has been decreasing by -1.69% on average per year.
EPS 1Y (TTM)98.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)39.86%
Revenue growth 3Y16.09%
Revenue growth 5Y-1.69%
Sales Q2Q%206.87%

3.2 Future

The Earnings Per Share is expected to grow by 36.64% on average over the next years. This is a very strong growth
CNVS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.97% yearly.
EPS Next Y103.7%
EPS Next 2Y36.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year53%
Revenue Next 2Y21.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNVS Yearly Revenue VS EstimatesCNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CNVS Yearly EPS VS EstimatesCNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80 -100

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CNVS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNVS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVS Price Earnings VS Forward Price EarningsCNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

CNVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CNVS is cheaper than 88.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CNVS is valued a bit cheaper than 70.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.58
EV/EBITDA 5.76
CNVS Per share dataCNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

CNVS's earnings are expected to grow with 36.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.64%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CINEVERSE CORP

NASDAQ:CNVS (6/12/2025, 8:00:00 PM)

After market: 3.85 +0.01 (+0.26%)

3.84

-0.08 (-2.04%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)06-30 2025-06-30/amc
Inst Owners15.47%
Inst Owner Change-5.05%
Ins Owners12.7%
Ins Owner Change4.67%
Market Cap61.36M
Analysts82.5
Price Target8.67 (125.78%)
Short Float %1.6%
Short Ratio3.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.88%
Min EPS beat(2)9.29%
Max EPS beat(2)26.47%
EPS beat(4)3
Avg EPS beat(4)14.23%
Min EPS beat(4)-50.83%
Max EPS beat(4)71.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.01%
Min Revenue beat(2)9.79%
Max Revenue beat(2)16.23%
Revenue beat(4)2
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-15.94%
Max Revenue beat(4)16.23%
Revenue beat(8)2
Avg Revenue beat(8)-3.31%
Revenue beat(12)6
Avg Revenue beat(12)7.35%
Revenue beat(16)9
Avg Revenue beat(16)7.26%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF 28.58
P/OCF 16.68
P/B 1.64
P/tB 4.8
EV/EBITDA 5.76
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.13
FCFY3.5%
OCF(TTM)0.23
OCFY6%
SpS4.53
BVpS2.34
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.3%
ROE -32.93%
ROCE 15.83%
ROIC 11.32%
ROICexc 13.31%
ROICexgc 46.31%
OM 8.04%
PM (TTM) N/A
GM 53.4%
FCFM 2.96%
ROA(3y)-14.52%
ROA(5y)-28.21%
ROE(3y)-28.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.81%
GM growth 5Y-2.67%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.79
Debt/EBITDA 0.4
Cap/Depr 40.67%
Cap/Sales 2.11%
Interest Coverage 5.42
Cash Conversion 38.35%
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z -6.63
F-Score6
WACC8.74%
ROIC/WACC1.3
Cap/Depr(3y)25.17%
Cap/Depr(5y)25.31%
Cap/Sales(3y)1.73%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y103.7%
EPS Next 2Y36.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)39.86%
Revenue growth 3Y16.09%
Revenue growth 5Y-1.69%
Sales Q2Q%206.87%
Revenue Next Year53%
Revenue Next 2Y21.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y234.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year442.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y125.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.35%
OCF growth 3YN/A
OCF growth 5YN/A